Biomadison competitive analysis

Latest publications and patents of Biomadison New

Explore the latest publications and patents granted to Biomadison, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biomadison

Apr 3, 2024Botulinum Toxin Assay With Improved SensitivityPatent Maintained As Amended
Aug 16, 2023Botulinum Toxin Assay With Improved SensitivityPatent Maintained As Amended
May 16, 2018Methods And Compounds For Increasing Sensitivity Of Botulinum AssaysRevoked

Explore Biomadison's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 3, 2024Botulinum Toxin Assay With Improved Sensitivity1
Aug 16, 2023Botulinum Toxin Assay With Improved Sensitivity1
May 16, 2018Methods And Compounds For Increasing Sensitivity Of Botulinum Assays1

Latest PTAB cases involving Biomadison

Discover the latest PTAB cases involving Biomadison, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biomadison with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BIOMADISON - 3 - - Non-Active
MERZ PHARMA176 - - Highly Aggressive